Erratum: miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress (EMBO Journal (2011) 30 (524-532) DOI: 10.1038/emboj.2010.347);MiR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress

EMBO Journal

Volumn 30, Issue 3, 2011, Pages 524-532

  Xiao, Jiening ^a,b   Lin, Huixian ^a,b   Luo, Xiaobin ^a   Luo, Xiaoyan ^a   Wang, Zhiguo ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b GUANGZHOU UNIVERSITY   (China)

Author keywords

apoptosis; gene expression; Mdm2; miRNA; p53

Indexed keywords

CASPASE 3; LUCIFERASE; MESSENGER RNA; MICRORNA; NUTLIN 3; PIFITHRIN ALPHA; PROTEIN MDM2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL STRAIN MCF 7; CELL STRESS; CELL SURVIVAL; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

EID: 79551610902     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.463     Document Type: Erratum

References (34)

1. Barak Y, Juven T, Haffner R, Oren M (1993) mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468
2. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497-1501
3. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752
4. Dickens MP, Fitzgerald R, Fischer PM (2010) Small-molecule inhibitors of MDM2 as new anticancer therapeutics. Semin Cancer Biol 20: 10-18
5. Eischen CM, Lozano G (2009) p53 and MDM2: antagonists or partners in crime? Cancer Cell 15: 161-162
6. Ericson K, Gan C, Cheong I, Rago C, Samuels Y, Velculescu VE, Kinzler KW, Huso DL, Vogelstein B, Papadopoulos N (2010) Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Proc Natl Acad Sci USA 107: 2598-2603
7. Gao H, Xiao J, Yang B, Sun Q, Lin H, Bai Y, Yang L, Wang H, Wang Z (2006) A single decoy oligodeoxynucleotides targeting multiple oncoproteins produces strong anti-cancer effects. Mol Pharmacol 70: 1621-1629
8. Han H, Wang H, Long H, Nattel S, Wang Z (2001) Oxidative preconditioning and apoptosis in L-cells: roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 276: 26357-26364
9. Harris SL, Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908
10. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
11. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134
12. Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199
13. Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420: 25-27
14. Keimling M, Wiesmüller L (2009) DNA double-strand break repair activities in mammary epithelial cells-influence of endogenous p53 variants. Carcinogenesis 30: 1260-1268
15. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
16. Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289
17. 0-UTR interaction sites. Genome Res 19: 1175-1183
18. + channel gene mediates cell-growth signals on activation of oncoproteins Sp1 and NF-kB and inactivation of tumor suppressor Nkx3.1. J Cell Physiol 212: 137-147
19. Lu Y, Xiao J, Lin H, Bai Y, Luo X, Wang Z, Yang B (2009) Complex antisense inhibitors offer a superior approach for microRNA research and therapy. Nucleic Acids Res 37: e24-e33
20. Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z (2008) Overexpression of Sp1 and downregulation of miR-1/miR-133 activates re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 283: 20045-20052
21. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245
22. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T (1997) In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 13: 894-899
23. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743
24. Rokhlin OW, Scheinker VS, Taghiyev AF, Bumcrot D, Glover RA, Cohen MB (2008) MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther 7: 1288-1296
25. Shangary S, Wang S (2009) Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol 49: 223-241
26. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, Hermeking H (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593
27. Vassilev LT (2007) MDM2 inhibitors for cancer therapy. Trends Mol Med 13: 23-31
28. Wade M, Wang YV, Wahl GM (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20: 299-309
29. + channel: a regulator of tumor cell apoptosis and proliferation. Cancer Res 62: 4843-4848
30. Weber L (2010) Patented inhibitors of p53-Mdm2 interaction (2006- 2008). Expert Opin Ther Pat 20: 179-191
31. Welch C, Chen Y, Stallings RL (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblas-toma cells. Oncogene 26: 5017-5022
32. + channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282: 12363-12367
33. Xu C, Lu Y, Lin H, Xiao J, Wang H, Luo X, Li B, Wang Z, Yang B (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis via targeting HSP60/HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120: 3045-3052
34. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z (2007) The muscle-specific microRNA miR-1 causes cardiac arrhythmias by targeting GJA1 and KCNJ2 genes. Nat Med 13: 486-491